In trading on Wednesday, shares of Synageva BioPharma Corp (GEVA) crossed below their 200 day moving average of $49.95, changing hands as low as $49.43 per share. Synageva BioPharma Corp shares are currently trading off about 4.4% on the day. The chart below shows the one year performance of GEVA shares, versus its 200 day moving average:Looking at the chart above, GEVA's low point in its 52 week range is $34.01 per share, with $58.00 as the 52 week high point — that compares with a last trade of $49.41. According to the ETF Finder at ETF Channel, GEVA makes up 1.23% of the SPDR S&P Biotech ETF ( XBI) which is trading lower by about 1.2% on the day Wednesday.
More from Stocks
Backtracking Fed Puts an End to Market Celebration
After what happened to Microsoft stock on its superb report we now have to be a little concerned.
Stocks End Lower Friday Ahead of Busy Earnings Week
Stocks slumped at the close to end down Friday as as investors digested a series of quarterly earnings reports.
Pier 1 Shares Close Lower; Retailer Names New President, CFO
Shares of home-décor retailer Pier 1 closed lower on Friday. The company made two new senior executive appointments to help it stanch declining sales.
CrowdStrike Shares Surge on Strong First Earnings Report
The cybersecurity company, which the FBI used to assess the Russian hacking of the DNC, also offered investors stronger-than-expected growth projections.
Microsoft Hits Record High as Cloud Revenues Drive Q4 Earnings Beat
Microsoft shares traded at an all-time high Friday, lifting the world's most valuable company well past $1 trillion, after the tech giant posted stronger-than-expected fourth quarter earnings driven largely by its fast-expanding cloud computing business.